Abstract
The purpose of this paper was to describe a patient with pericentral retinitis pigmentosa (RP) and cystoid macular edema (CME) refractory to oral acetazolamide alone who was successfully treated with adjunctive pegaptanib sodium. A 33-year-old man presented with decreased vision and a best-corrected visual acuity (BCVA) in his left eye of 20/200 due to CME secondary to RP. Although he had been treated daily for 1 month with 500 mg of oral acetazolamide, the edema was unresponsive. When informed of the available treatment options, the patient requested adjunctive intravitreal pegaptanib sodium. One month after receiving an injection of pegaptanib sodium 0.3 mg and continued daily acetazolamide, the patient’s BCVA had improved to 20/40. At the 4-month follow-up visit, no recurrence of CME was found on fundus biomicroscopy, fundus-related perimetry, and optical coherence tomography. We conclude that intravitreal pegaptanib sodium combined with daily doses of acetazolamide appears to provide benefits in CME refractory to oral acetazolamide alone with regards to the improvement of visual acuity.
Similar content being viewed by others
References
Sandberg MA, Gaudio AR, Berson EL (2005) Disease course of patients with pericentral retinitis pigmentosa. Am J Ophthalmol 140:100–106
Noble KG, Carr RE (1978) Peripapillary pigmentary retinal degeneration. Am J Ophthalmol 86:65–75
Hayasaka S, Fukuda K, Tsuchiya M, Mizuno K (1985) Pericentral pigmentary retinal degeneration. Jpn J Ophthalmol 29:161–169
Yamaguchi K, Kin-Para Y, Tamai M (1991) Idiopathic central serous choroidopathy in a patient with pericentral pigmentary retinal degeneration. Ann Ophthalmol 23:251–253
Fenkenhour CL, Choromokos E, Weinstein J, Shoch D (1977) Cystoid macular oedema in retinitis pigmentosa. Trans Am Acad Ophthalmol Otolaryngol 83:515–521
Fishman GA, Maggiano JM, Fishman M (1977) Foveal lesions seen in retinitis pigmentosa. Arch Ophthalmol 95:1993–1996
Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106:1190–1195
Saraiva VS, Sallum JM, Farah ME (2003) Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 34:398–400
García-Arumi J, Martinez V, Sararols L, Corcostegui B (2003) Vitreoretinal surgery for cystoid macular edema associated with retinitis pigmentosa. Ophthalmology 110:1164–1169
Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group (2004) Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351:2805–2816
Vinores SA, Youssri AI, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA (1997) Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99–109
Melo GB, Farah ME, Aggio FB (2007) Intravitreal injection of bevacizumab for cystoid macular edema in retinitis pigmentosa. Acta Ophthalmol Scand 85:461–463
Nao-i N, Fukiyama J, Sawada A (1996) Retinitis pigmentosa with recurrent vitreous hemorrhage. Acta Ophthalmol Scand 74:509–512
Kadayifçilar S, Eldem B, Kiratli H (2000) Retinitis pigmentosa associated with peripheral sea fan neovascularization. Acta Ophthalmol Scand 78:593–595
Arden GB (2001) The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment. Br J Ophthalmol 85:366–370
Lahdenranta J, Pasqualini R, Schlingemann RO, Hagedorn M, Stallcup WB, Bucana CD, Sidman RL, Arap W (2001) An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration. Proc Natl Acad Sci USA 98:10368–10373
Heckenlively JR, Jordan BL, Aptsiauri N (1999) Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 127:565–573
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have no proprietary interest in the materials used in this study.
Rights and permissions
About this article
Cite this article
Querques, G., Prascina, F., Iaculli, C. et al. Intravitreal pegaptanib sodium (Macugen) for refractory cystoid macular edema in pericentral retinitis pigmentosa. Int Ophthalmol 29, 103–107 (2009). https://doi.org/10.1007/s10792-007-9175-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-007-9175-1